Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of “Humanized” Multiple Sclerosis-like Disease*
暂无分享,去创建一个
M. Eisenstein | H. Lassmann | G. Zeilig | A. Ben-nun | D. Altmann | B. Hansen | C. Nielsen | R. Milo | N. Kaushansky | S. Boura-Halfon
[1] M. Carrington,et al. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects , 2013, PLoS genetics.
[2] W. Brown,et al. Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements , 2012, Immunogenetics.
[3] H. Lassmann,et al. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP) , 2012, Journal of Neuroinflammation.
[4] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[5] M. Eisenstein,et al. Computational mapping of anchoring spots on protein surfaces. , 2010, Journal of molecular biology.
[6] S. Baranzini,et al. Multiple sclerosis genetics—is the glass half full, or half empty? , 2010, Nature Reviews Neurology.
[7] H. Lassmann,et al. HLA-DQB1*0602 Determines Disease Susceptibility in a New “Humanized” Multiple Sclerosis Model in HLA-DR15 (DRB1*1501;DQB1*0602) Transgenic Mice1 , 2009, The Journal of Immunology.
[8] Sreeram V Ramagopalan,et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility , 2009, Proceedings of the National Academy of Sciences.
[9] M. Eisenstein,et al. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M). , 2008, International immunology.
[10] Moses Rodriguez,et al. HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-γ1 , 2008, The Journal of Immunology.
[11] A. Ben-nun,et al. Oligodendrocyte‐specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve , 2008, European journal of immunology.
[12] M. Eisenstein,et al. OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207 , 2007, European journal of immunology.
[13] H. Lassmann,et al. Epitope Specificity of Autoreactive T and B Cells Associated with Experimental Autoimmune Encephalomyelitis and Optic Neuritis Induced by Oligodendrocyte-Specific Protein in SJL/J Mice1 , 2006, The Journal of Immunology.
[14] S. Hauser,et al. The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration , 2006, Neuron.
[15] Lon R. Cardon,et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis , 2006, Nature.
[16] M. Eisenstein,et al. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG‐reactive T cells in H‐2b mice , 2006, European journal of immunology.
[17] Moses Rodriguez,et al. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice , 2005, Journal of Neuroimmunology.
[18] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[19] R. Hohlfeld,et al. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[21] M. Eisenstein,et al. The Myelin-Associated Oligodendrocytic Basic Protein Region MOBP15–36 Encompasses the Immunodominant Major Encephalitogenic Epitope(s) for SJL/J Mice and Predicted Epitope(s) for Multiple Sclerosis-Associated HLA-DRB1*15011 , 2004, The Journal of Immunology.
[22] L. Fugger,et al. Myelin oligodendrocyte glycoprotein‐35–55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA‐DR2‐transgenic mice , 2004, European journal of immunology.
[23] J. Trowsdale,et al. MHC class II sequences of an HLA-DR2 narcoleptic , 2004, Immunogenetics.
[24] Moses Rodriguez,et al. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. , 2003, International immunology.
[25] D. Baker,et al. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice , 2002, Journal of Neuroimmunology.
[26] T‐cell responses to oligodendrocyte‐specific protein in multiple sclerosis , 2001, Journal of neuroscience research.
[27] A. Meshorer,et al. T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2b and H-2s mice , 2000, Journal of Neuroimmunology.
[28] G. Ellison,et al. A humoral response to oligodendrocyte-specific protein in MS , 1999, Neurology.
[29] L. Fugger,et al. Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells. , 2008, Tissue antigens.
[30] Don C. Wiley,et al. Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.
[31] A. Ben-nun,et al. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein. , 1998, Journal of autoimmunity.
[32] J. Bronstein,et al. Oligodendrocyte‐specific protein (OSP) is a major component of CNS myelin , 1997, Journal of neuroscience research.
[33] J. Bronstein,et al. Isolation and characterization of a novel oligodendrocyte-specific protein , 1996, Neurology.
[34] J. Strominger,et al. Expression of Recombinant HLA-DR2 Molecules , 1996, The Journal of Biological Chemistry.
[35] J. Hillert,et al. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.
[36] H. Inoko,et al. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4 , 1995, The Journal of experimental medicine.
[37] J. Bodmer,et al. HLA Class II nucleotide sequences, 1992. , 1993, Immunobiology.
[38] J. Hillert,et al. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.
[39] H. Weiner,et al. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.
[40] V. Lotteau,et al. Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA , 1989, The Journal of experimental medicine.
[41] V. Lotteau,et al. A novel HLA class II molecule (DRα–sDQβ) created by mismatched isotype pairing , 1987, Nature.
[42] L. Hood,et al. Cotransfer of the Ed alpha and Ad beta genes into L cells results in the surface expression of a functional mixed-isotype Ia molecule. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Knobler,et al. Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition , 1985, The Journal of experimental medicine.
[44] J. D. Capra,et al. Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Penninger,et al. Brief Definitive Report , 2003 .
[46] V. Lotteau,et al. Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation , 1984, Nature.
[47] H. Mcdevitt,et al. Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant , 1984, The Journal of experimental medicine.
[48] A. Ben-nun,et al. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. , 1983, Journal of immunology.
[49] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[50] I. Cohen,et al. Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein , 1981, Nature.
[51] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.